Terms: = Breast cancer AND CCNE1, CCNE, 898, ENSG00000105173, P24864 AND Prognosis
39 results:
1. Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer.
Liu Z; Yu B; Su M; Yuan C; Liu C; Wang X; Song X; Li C; Wang F; Ma J; Wu M; Chen D; Yu J; Yu Z
BMC Med; 2023 Dec; 21(1):493. PubMed ID: 38087296
[TBL] [Abstract] [Full Text] [Related]
2. ccne1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.
Kang EY; Weir A; Meagher NS; Farrington K; Nelson GS; Ghatage P; Lee CH; Riggan MJ; Bolithon A; Popovic G; Leung B; Tang K; Lambie N; Millstein J; Alsop J; Anglesio MS; Ataseven B; Barlow E; Beckmann MW; Berger J; Bisinotto C; Bösmüller H; Boros J; Brand AH; Brooks-Wilson A; Brucker SY; Carney ME; Casablanca Y; Cazorla-Jiménez A; Cohen PA; Conrads TP; Cook LS; Coulson P; Courtney-Brooks M; Cramer DW; Crowe P; Cunningham JM; Cybulski C; Darcy KM; El-Bahrawy MA; Elishaev E; Erber R; Farrell R; Fereday S; Fischer A; García MJ; Gayther SA; Gentry-Maharaj A; Gilks CB; ; Grube M; Harnett PR; Harrington SP; Harter P; Hartmann A; Hecht JL; Heikaus S; Hein A; Heitz F; Hendley J; Hernandez BY; Polo SH; Heublein S; Hirasawa A; Høgdall E; Høgdall CK; Horlings HM; Huntsman DG; Huzarski T; Jewell A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Khabele D; Kommoss FKF; Kruitwagen RFPM; Lambrechts D; Le ND; Lener M; Lester J; Leung Y; Linder A; Loverix L; Lubiński J; Madan R; Maxwell GL; Modugno F; Neuhausen SL; Olawaiye A; Olbrecht S; Orsulic S; Palacios J; Pearce CL; Pike MC; Quinn CM; Mohan GR; Rodríguez-Antona C; Ruebner M; Ryan A; Salfinger SG; Sasamoto N; Schildkraut JM; Schoemaker MJ; Shah M; Sharma R; Shvetsov YB; Singh N; Sonke GS; Steele L; Stewart CJR; Sundfeldt K; Swerdlow AJ; Talhouk A; Tan A; Taylor SE; Terry KL; Tołoczko A; Traficante N; Van de Vijver KK; van der Aa MA; Van Gorp T; Van Nieuwenhuysen E; van-Wagensveld L; Vergote I; Vierkant RA; Wang C; Wilkens LR; Winham SJ; Wu AH; Benitez J; Berchuck A; Candido Dos Reis FJ; DeFazio A; Fasching PA; Goode EL; Goodman MT; Gronwald J; Karlan BY; Kommoss S; Menon U; Sinn HP; Staebler A; Brenton JD; Bowtell DD; Pharoah PDP; Ramus SJ; Köbel M
Cancer; 2023 Mar; 129(5):697-713. PubMed ID: 36572991
[TBL] [Abstract] [Full Text] [Related]
3. Incorporating progesterone receptor expression into the PREDICT breast prognostic model.
Grootes I; Keeman R; Blows FM; Milne RL; Giles GG; Swerdlow AJ; Fasching PA; Abubakar M; Andrulis IL; Anton-Culver H; Beckmann MW; Blomqvist C; Bojesen SE; Bolla MK; Bonanni B; Briceno I; Burwinkel B; Camp NJ; Castelao JE; Choi JY; Clarke CL; Couch FJ; Cox A; Cross SS; Czene K; Devilee P; Dörk T; Dunning AM; Dwek M; Easton DF; Eccles DM; Eriksson M; Ernst K; Evans DG; Figueroa JD; Fink V; Floris G; Fox S; Gabrielson M; Gago-Dominguez M; García-Sáenz JA; González-Neira A; Haeberle L; Haiman CA; Hall P; Hamann U; Harkness EF; Hartman M; Hein A; Hooning MJ; Hou MF; Howell SJ; ; ; Ito H; Jakubowska A; Janni W; John EM; Jung A; Kang D; Kristensen VN; Kwong A; Lambrechts D; Li J; Lubiński J; Manoochehri M; Margolin S; Matsuo K; Taib NAM; Mulligan AM; Nevanlinna H; Newman WG; Offit K; Osorio A; Park SK; Park-Simon TW; Patel AV; Presneau N; Pylkäs K; Rack B; Radice P; Rennert G; Romero A; Saloustros E; Sawyer EJ; Schneeweiss A; Schochter F; Schoemaker MJ; Shen CY; Shibli R; Sinn P; Tapper WJ; Tawfiq E; Teo SH; Teras LR; Torres D; Vachon CM; van Deurzen CHM; Wendt C; Williams JA; Winqvist R; Elwood M; Schmidt MK; García-Closas M; Pharoah PDP
Eur J Cancer; 2022 Sep; 173():178-193. PubMed ID: 35933885
[TBL] [Abstract] [Full Text] [Related]
4. CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer.
Aiyappa-Maudsley R; Storr SJ; Rakha EA; Green AR; Ellis IO; Martin SG
J Pathol Clin Res; 2022 Nov; 8(6):550-566. PubMed ID: 35902379
[TBL] [Abstract] [Full Text] [Related]
5. The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and prognosis of Patients With breast cancer.
Wang B; Liu J; Han Y; Deng Y; Li J; Jiang Y
Front Immunol; 2022; 13():868155. PubMed ID: 35664009
[TBL] [Abstract] [Full Text] [Related]
6. High cyclin E1 protein, but not gene amplification, is prognostic for basal-like breast cancer.
Aziz D; Lee C; Chin V; Fernandez KJ; Phan Z; ; ; Waring P; Caldon CE
J Pathol Clin Res; 2022 Jul; 8(4):355-370. PubMed ID: 35384378
[TBL] [Abstract] [Full Text] [Related]
7. Multi-omics analyses provide novel biological insights to distinguish lobular ductal types of invasive breast cancers.
Sivadas A; Kok VC; Ng KL
Breast Cancer Res Treat; 2022 Jun; 193(2):361-379. PubMed ID: 35348974
[TBL] [Abstract] [Full Text] [Related]
8. Uterine serous carcinoma: key advances and novel treatment approaches.
Ferriss JS; Erickson BK; Shih IM; Fader AN
Int J Gynecol Cancer; 2021 Aug; 31(8):1165-1174. PubMed ID: 34210768
[TBL] [Abstract] [Full Text] [Related]
9. Overexpression of ccne1 confers a poorer prognosis in triple-negative breast cancer identified by bioinformatic analysis.
Yuan Q; Zheng L; Liao Y; Wu G
World J Surg Oncol; 2021 Mar; 19(1):86. PubMed ID: 33757543
[TBL] [Abstract] [Full Text] [Related]
10. Large-scale tumor-associated collagen signatures identify high-risk breast cancer patients.
Xi G; Guo W; Kang D; Ma J; Fu F; Qiu L; Zheng L; He J; Fang N; Chen J; Li J; Zhuo S; Liao X; Tu H; Li L; Zhang Q; Wang C; Boppart SA; Chen J
Theranostics; 2021; 11(7):3229-3243. PubMed ID: 33537084
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events.
Zeng KL; Sahgal A; Tseng CL; Myrehaug S; Soliman H; Detsky J; Atenafu EG; Lee Y; Campbell M; Maralani P; Husain ZA
Neurosurgery; 2021 Apr; 88(5):971-979. PubMed ID: 33475723
[TBL] [Abstract] [Full Text] [Related]
12. Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy tools.
Gerratana L; Davis AA; Polano M; Zhang Q; Shah AN; Lin C; Basile D; Toffoli G; Wehbe F; Puglisi F; Behdad A; Platanias LC; Gradishar WJ; Cristofanilli M
Eur J Cancer; 2021 Jan; 143():147-157. PubMed ID: 33307492
[TBL] [Abstract] [Full Text] [Related]
13. ccne1 amplification is associated with poor prognosis in patients with triple negative breast cancer.
Zhao ZM; Yost SE; Hutchinson KE; Li SM; Yuan YC; Noorbakhsh J; Liu Z; Warden C; Johnson RM; Wu X; Chuang JH; Yuan Y
BMC Cancer; 2019 Jan; 19(1):96. PubMed ID: 30665374
[TBL] [Abstract] [Full Text] [Related]
14. The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating ccne1 expression.
Yang R; Xing L; Zheng X; Sun Y; Wang X; Chen J
Mol Cancer; 2019 Jan; 18(1):4. PubMed ID: 30621700
[TBL] [Abstract] [Full Text] [Related]
15. Digital quantification of KI-67 in breast cancer.
Del Rosario Taco Sanchez M; Soler-Monsó T; Petit A; Azcarate J; Lasheras A; Artal C; Gil M; Falo C; Pla MJ; Matias-Guiu X
Virchows Arch; 2019 Feb; 474(2):169-176. PubMed ID: 30465110
[TBL] [Abstract] [Full Text] [Related]
16. Identification of key candidate genes, pathways and related prognostic values in ER-negative/HER2-negative breast cancer by bioinformatics analysis.
Shao N; Yuan K; Zhang Y; Yun Cheang T; Li J; Lin Y
J BUON; 2018; 23(4):891-901. PubMed ID: 30358191
[TBL] [Abstract] [Full Text] [Related]
17. Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese breast cancer Registry.
Kataoka A; Iwamoto T; Tokunaga E; Tomotaki A; Kumamaru H; Miyata H; Niikura N; Kawai M; Anan K; Hayashi N; Masuda S; Tsugawa K; Aogi K; Ishida T; Masuoka H; Iijima K; Kinoshita T; Nakamura S; Tokuda Y
Breast Cancer Res Treat; 2016 Nov; 160(1):163-172. PubMed ID: 27647460
[TBL] [Abstract] [Full Text] [Related]
18. Comparison of Clinical Outcomes of
Eoh KJ; Park HS; Park JS; Lee ST; Han J; Lee JY; Kim SW; Kim S; Kim YT; Nam EJ
Cancer Res Treat; 2017 Apr; 49(2):408-415. PubMed ID: 27488874
[TBL] [Abstract] [Full Text] [Related]
19. [Estimation of venous thromboembolism risk with thrombotic biomarkers in cancer patients].
Jianlong M; Diansheng Z; Jing R
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):283-9. PubMed ID: 26462893
[TBL] [Abstract] [Full Text] [Related]
20. The effect of obesity on recurrence pattern in early breast cancer patients.
Yazici O; Aksoy S; Sendur MA; Babacan T; Ozdemir N; Ozisik Y; Zengin N; Altundag K
J BUON; 2015; 20(4):954-62. PubMed ID: 26416043
[TBL] [Abstract] [Full Text] [Related]
[Next]
